Total Payments
$3,470
2024 Payments
$292.97
Companies
31
Transactions
180
Medicare Patients
5,248
Medicare Billing
$789,870
Payment Breakdown by Category
Food & Beverage$3,466 (99.9%)
Education$4.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,466 | 179 | 99.9% |
| Education | $4.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,000 | 68 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $721.24 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $370.89 | 24 | $0 (2021) |
| United Therapeutics Corporation | $244.23 | 6 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $128.64 | 3 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $112.02 | 8 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $105.24 | 5 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $102.23 | 4 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $75.89 | 5 | $0 (2022) |
| Gilead Sciences, Inc. | $55.24 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $292.97 | 6 | United Therapeutics Corporation ($128.64) |
| 2023 | $233.78 | 11 | GlaxoSmithKline, LLC. ($117.57) |
| 2022 | $149.08 | 8 | GlaxoSmithKline, LLC. ($58.61) |
| 2021 | $321.59 | 17 | Mallinckrodt Hospital Products Inc. ($102.23) |
| 2020 | $298.67 | 17 | GlaxoSmithKline, LLC. ($71.69) |
| 2019 | $257.51 | 16 | GlaxoSmithKline, LLC. ($56.45) |
| 2018 | $756.98 | 52 | GlaxoSmithKline, LLC. ($290.08) |
| 2017 | $1,160 | 53 | AstraZeneca Pharmaceuticals LP ($327.79) |
All Payment Transactions
180 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $102.00 | General |
| 06/26/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 05/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: RESPIRATORY | ||||||
| 03/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: RESPIRATORY | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $94.28 | General |
| Category: Oncology | ||||||
| 02/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Inflammation | ||||||
| 09/15/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $14.68 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: RESPIRATORY | ||||||
| 04/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: RESPIRATORY | ||||||
| 04/13/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: IMMUNOLOGY | ||||||
| 03/31/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Immunology | ||||||
| 03/30/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $35.43 | General |
| Category: NEUROLOGY | ||||||
| 03/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Respiratory | ||||||
| 10/25/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: RESPIRATORY | ||||||
| 08/17/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Cardiology | ||||||
| 08/08/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Respiratory | ||||||
| 01/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 709 | 1,114 | $571,676 | $127,268 |
| 2022 | 12 | 900 | 1,435 | $674,405 | $153,424 |
| 2021 | 19 | 1,578 | 2,211 | $617,702 | $218,206 |
| 2020 | 21 | 2,061 | 3,139 | $790,835 | $290,972 |
Total Patients
5,248
Total Services
7,899
Medicare Billing
$789,870
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 264 | 517 | $217,906 | $48,934 | 22.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 116 | 220 | $169,739 | $37,758 | 22.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 185 | 192 | $120,293 | $25,497 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 63 | $24,006 | $5,899 | 24.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 87 | $24,836 | $5,391 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $11,940 | $3,052 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,956 | $737.74 | 25.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 163 | 377 | $315,475 | $62,102 | 19.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 250 | 493 | $152,706 | $40,382 | 26.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 176 | 185 | $111,640 | $28,069 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 129 | $49,536 | $11,932 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $14,196 | $3,367 | 23.7% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 17 | 25 | $9,325 | $2,163 | 23.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 28 | $6,093 | $1,615 | 26.5% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 13 | 13 | $5,785 | $1,440 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 19 | $5,187 | $1,263 | 24.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 46 | 46 | $1,702 | $419.02 | 24.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 46 | 46 | $1,472 | $359.51 | 24.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 46 | 46 | $1,288 | $313.05 | 24.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 146 | 423 | $250,914 | $76,114 | 30.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 197 | 430 | $98,018 | $36,139 | 36.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 194 | 247 | $58,760 | $26,247 | 44.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 131 | 133 | $59,542 | $21,556 | 36.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 84 | 99 | $29,700 | $13,843 | 46.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 136 | 157 | $24,418 | $9,830 | 40.3% |
About Dr. Sandeep Chennadi, M.D
Dr. Sandeep Chennadi, M.D is a Pulmonary Disease healthcare provider based in Wesley Chapel, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1376869768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandeep Chennadi, M.D has received a total of $3,470 in payments from pharmaceutical and medical device companies, with $292.97 received in 2024. These payments were reported across 180 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,466).
As a Medicare-enrolled provider, Chennadi has provided services to 5,248 Medicare beneficiaries, totaling 7,899 services with total Medicare billing of $789,870. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Wesley Chapel, FL
- Active Since 04/11/2010
- Last Updated 03/18/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1376869768
Products in Payments
- TRELEGY ELLIPTA (Drug) $514.28
- BEVESPI AEROSPHERE (Drug) $354.09
- BREO (Drug) $188.62
- NUCALA (Biological) $188.07
- FASENRA (Drug) $185.33
- OFEV (Drug) $156.34
- STIOLTO RESPIMAT (Drug) $150.72
- ANORO (Drug) $109.32
- NIOX VERO DEVICE (Device) $104.16
- ACTHAR (Biological) $102.23
- TAGRISSO (Drug) $94.28
- ORENITRAM (Drug) $91.68
- DUPIXENT (Biological) $85.58
- STIOLTO (Drug) $63.83
- UTIBRON (Drug) $61.17
- OPSUMIT (Drug) $46.68
- SYMBICORT (Drug) $42.02
- Yupelri (Drug) $39.84
- Astral (Device) $39.38
- UPTRAVI (Drug) $38.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.